Found: 14
Select item for more details and to access through your institution.
Application of Microphysiological Systems for Nonclinical Evaluation of Cell Therapies.
- Published in:
- Altex, 2024, v. 41, n. 3, p. 469, doi. 10.14573/altex.2402201
- By:
- Publication type:
- Article
An Extensive Metabolomics Workflow to Discover Cardiotoxin-Induced Molecular Perturbations in Microtissues.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 9, p. 644, doi. 10.3390/metabo11090644
- By:
- Publication type:
- Article
Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40333-7
- By:
- Publication type:
- Article
Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012733
- By:
- Publication type:
- Article
On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45656-4
- By:
- Publication type:
- Article
Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1372817
- By:
- Publication type:
- Article
RYR2 deficient human model identifies calcium handling and metabolic dysfunction impacting pharmacological responses.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1357315
- By:
- Publication type:
- Article
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214545
- By:
- Publication type:
- Article
Computational approaches identify a transcriptomic fingerprint of drug-induced structural cardiotoxicity.
- Published in:
- Cell Biology & Toxicology, 2024, v. 40, n. 1, p. 1, doi. 10.1007/s10565-024-09880-7
- By:
- Publication type:
- Article
High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery.
- Published in:
- Toxicological Sciences, 2017, v. 155, n. 2, p. 444, doi. 10.1093/toxsci/kfw227
- By:
- Publication type:
- Article
Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.
- Published in:
- Toxicological Sciences, 2016, v. 152, n. 1, p. 99, doi. 10.1093/toxsci/kfw069
- By:
- Publication type:
- Article
Enhanced Characterization of Contractility in Cardiomyocytes During Early Drug Safety Assessment.
- Published in:
- Toxicological Sciences, 2015, v. 145, n. 2, p. 396, doi. 10.1093/toxsci/kfv062
- By:
- Publication type:
- Article
Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
- Published in:
- Toxicological Sciences, 2015, v. 144, n. 2, p. 227, doi. 10.1093/toxsci/kfu312
- By:
- Publication type:
- Article
Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity.
- Published in:
- Toxicological Sciences, 2013, v. 132, n. 2, p. 317, doi. 10.1093/toxsci/kft005
- By:
- Publication type:
- Article